Pantoprazole and Edaravone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Edaravone (edaravone). Common drug interactions include asthenia among females and cerebral infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Edaravone. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Edaravone?

Edaravone has active ingredients of edaravone. eHealthMe is studying from 695 Edaravone users. Check the latest studies of Edaravone.

On Jul, 16, 2026

12 people who take Pantoprazole and Edaravone together, and have interactions are studied.

Pantoprazole and Edaravone drug interactions.

What are the common drug interactions of Pantoprazole and Edaravone, by gender? *:

female:

Asthenia (weakness)
Speech disorder
Tremor (trembling or shaking movements in one or more parts of your body)
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
Cerebral haemorrhage (bleeding within the brain)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Hepatic failure (liver failure)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

male:

Cerebral infarction (less blood supply to brain resulting tissue damage)
Aspartate aminotransferase increased
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Cerebral haematoma (collection of blood in brain)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Haemorrhage urinary tract (bleeding from uterine)
Haemorrhagic cerebral infarction (brain stroke with bleeding)
Pneumonia
Blood bilirubin increased
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)

What are the common drug interactions of Pantoprazole and Edaravone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Aspartate aminotransferase increased
Blood bilirubin increased
Cerebral infarction (less blood supply to brain resulting tissue damage)

40-49:

n/a

50-59:

Hepatic enzyme increased
Hypokinesia (decreased bodily movement)
Hypotension (abnormally low blood pressure)
Pancreatic carcinoma (pancreatic cancer)
Poor venous access
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

60+:

Cerebral haemorrhage (bleeding within the brain)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
Cerebral haematoma (collection of blood in brain)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Haemorrhage urinary tract (bleeding from uterine)
Haemorrhagic cerebral infarction (brain stroke with bleeding)
Hepatic failure (liver failure)

What are the existing conditions these people have? *

Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 5 people, 41.67%
Hepatocellular Carcinoma (liver cancer): 4 people, 33.33%
Pain: 4 people, 33.33%
Diabetes: 4 people, 33.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 33.33%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 33.33%
Hepatitis (inflammation of the liver): 4 people, 33.33%
Hepatitis B: 4 people, 33.33%
Hepatitis Viral: 4 people, 33.33%
Reduction Of Increased Intracranial Pressure (reducing intracranial pressure): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Edaravone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously